At Organixia, our experts combine deep scientific insight with advanced analytical techniques to help you harness the full potential of your products.
Direct influence on API bio-availability.
Chemical and solid-state purity
Critical during formulation and scale-up.
Why polymorphism and co-crystals matter? Understanding and controlling the solid state of materials is critical for ensuring optimal performance, stability and production of active ingredients and intermediates.
Opportunities for differentiation and patenting.
Long-term storage behavior analysis.
Reduces process development risk.
We offer comprehensive screening programs to systematically identify and characterize all relevant crystalline forms of your compound. By carefully evaluating stability and transformation behavior under different conditions, we support selection of the most suitable solid form for formulation, processing, and further development.
Solvates and hydrates are commonly used in the API and food industries, while other solvates may serve as intermediate forms for purification or isolation. Solvate formation can therefore be essential in many cases. Our expertise enables clients to determine whether a solvate form should be avoided, stabilized, or utilized to achieve superior performance
Co-crystals are engineered crystalline materials composed of the active compound and a inactive co-former, bonded through non-covalent interactions such as hydrogen bonding. Unlike salts or solvates, co-crystals maintain the chemical identity of the active ingredient while offering a unique way to fine-tune its physical properties.
We combine crystallization expertise with understanding of API solid-state form selection with drug product performance in mind.
Leave us a short note using the form below and we’ll contact you promptly to discuss your request.